National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Status:
Recruiting
Trial end date:
2028-10-01
Target enrollment:
Participant gender:
Summary
A prospective, open label phase 2 clinical trial assessing safety, complications and
feasibility of radical prostatectomy (RARP) plus local stereotactic body radiotherapy (SBRT)
to bone metastases in combination with short-term medical castration to a select population
of prostate cancer patients with oligometastatic disease.